Andrew David Zelenetz

机构：Memorial Sloan Kettering Cancer Center, Cornell University, Presbyterian Hospital · ORCID：0000-0003-1403-6883

发表论文 757 篇 · 总被引 44105 次 · h-index 98

代表论文

• NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025 (2025 · Journal of the National Comprehensive Cancer Network · 被引 21)
• CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosis (2025 · Blood · 被引 10)
• Pirtobrutinib in Relapsed/Refractory (R/R) Mantle Cell Lymphoma (MCL): Final update from the Phase 1/2 BRUIN study (2025 · Blood · 被引 7)
• Treatment and outcomes of progression of disease post–CAR T-cell therapy in mantle cell lymphoma: a multicenter analysis (2025 · Blood Advances · 被引 7)
• Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53 -Mutated Diffuse Large B-Cell Lymphoma (2026 · Journal of Clinical Oncology · 被引 5)
• Preliminary safety and efficacy of boven (Zanubrutinib, Obinutuzumab, and Venetoclax) as frontline therapy for older patients with Mantle Cell Lymphoma (2025 · Blood · 被引 5)